drugset / Trial / NCT00137293

Study Evaluating GAP-486 in Heart Rhythm

NCT00137293 ↗

Phase 2 Terminated 30 enrolled Wyeth is now a wholly owned subsidiary of Pfizer
RandomizedParallel-groupDouble-blind

Summary

The purpose of this study is to learn the effects of a test drug on heart rhythm, and to provide additional data to see if the test drug is well tolerated and safe.

Timeline

Start
2005-11
Primary completion
—
Completion
2006-10

Drugs

EvaluationDrugModalityDoseRoute
Subject GAP-486 Unknown — —